<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Stephen A. Sherwin</title>
	<atom:link href="http://www.straightstocks.com/tag/stephen-a-sherwin/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Tue, 24 Nov 2009 14:06:55 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Cell Genesys, Inc. (CEGE) Halts Cancer Treatment Trial to Ensure Patient Safety</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/cell-genesys-inc-cege-halts-cancer-treatment-trial-to-ensure-patient-safety/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/cell-genesys-inc-cege-halts-cancer-treatment-trial-to-ensure-patient-safety/#comments</comments>
		<pubDate>Wed, 27 Aug 2008 16:49:48 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer Treatment]]></category>
		<category><![CDATA[Cell Genesys Inc.]]></category>
		<category><![CDATA[Independent Data Monitoring Committee]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[prednisone]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Stephen A. Sherwin]]></category>
		<category><![CDATA[Taxotere]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=11996</guid>
		<description><![CDATA[Cell Genesys, Inc. (Nasdaq: CEGE) focuses on the development and commercialization of biological therapies to treat multiple types of cancer. The company’s lead product platform, GVAX immunotherapy, holds the potential to treat various types of cancer, including prostate cancer, leukemia, pancreatic cancer and lung cancer. Cell Genesys today announced it has terminated VITAL-2, the second [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/cell-genesys-inc-cege-halts-cancer-treatment-trial-to-ensure-patient-safety/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
